Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Precigen Inc., 3 years.
Precigen Inc.
Director
BioCryst Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,262 | $8.91 | $11,244 |
| Mar 13, 2026 | Precigen Inc. | Option exercise | +71,839 | — | — |
| Mar 10, 2026 | Precigen Inc. | Grant or award | +14,245 | $3.51 | $50,000 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,285 | $8.75 | $11,244 |
| Nov 28, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,566 | $7.18 | $11,244 |
| Aug 29, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,353 | $8.31 | $11,243 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| May 30, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +333 | $10.75 | $3,580 |
| May 2, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,866 | — | — |
| Mar 14, 2025 | Precigen Inc. | Option exercise | +87,412 | — | — |
| Mar 13, 2025 | Precigen Inc. | Grant or award | +28,735 | $1.74 | $49,999 |
| Mar 14, 2024 | Precigen Inc. | Grant or award | +34,965 | $1.43 | $50,000 |
| Mar 9, 2024 | Precigen Inc. | Option exercise | +106,837 | — | — |
| Aug 14, 2023 | Precigen Inc. | Open-market purchase | +400,000 | $1.72 | $688,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.